Gemcitabine causes telomere attrition by stabilizing TRF2

European Journal of Cancer

Volumn 48, Issue 18, 2012, Pages 3465-3474

  Su, Chih Hao ^b   Chu, Wei Chih ^b   Lan, Keng Hsin ^a   Li, Chung Pin ^a   Chao, Yee ^a   Lin, Han Chieh ^a   Lee, Shou Dong ^a   Tsai, Ying Chieh ^b   Lee, Wei Ping ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gemcitabine; Telomere; TRF2

Indexed keywords

EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; GEMCITABINE; PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP F PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE; TELOMERE SHORTENING; WESTERN BLOTTING;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL DIVISION; CHROMATIN IMMUNOPRECIPITATION; DEOXYCYTIDINE; DNA, NEOPLASM; DNA-BINDING PROTEINS; ENDONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HALF-LIFE; HELA CELLS; HUMANS; NEOPLASM PROTEINS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY; RECOMBINANT FUSION PROTEINS; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 2; UBIQUITINATION; UP-REGULATION;

EID: 84869500777     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.04.015     Document Type: Article

References (31)

1. G. Qu, and E.A. Perez Gemcitabine and targeted therapy in metastatic breast cancer Semin Oncol 29 3 Suppl. 11 2002 44 52 (Pubitemid 34816065)
2. A. Depierre, V. Westeel, and P. Jacoulet Gemcitabine induction chemotherapy in non-small cell lung cancer Semin Oncol 29 3 Suppl. 9 2002 55 60 (Pubitemid 34753286)
3. V. Heinemann Present and future treatment of pancreatic cancer Semin Oncol 29 3 Suppl. 9 2002 23 31 (Pubitemid 34753280)
4. D.R. Fleming, S.D. Glisson, and L. Bhupalam Phase I study of paclitaxel and day 1/day 8 gemcitabine in patients with solid malignancies Am J Clin Oncol 23 2000 349 352 (Pubitemid 32429144)
5. D.R. Rauchwerger, P.S. Firby, D.W. Hedley, and M.J. Moore Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivity Cancer Res 60 2000 6075 6079
6. W.E. Schy, L.W. Hertel, and J.S. Kroin Effect of a template-located 2′, 2′-difluorodeoxycytidine on the kinetics and fidelity of base insertion by Klenow (3′ → 5′exonuclease) fragment Cancer Res 53 1993 4582 4587 (Pubitemid 23304383)
7. V.W. Ruiz van Haperen, G. Veerman, and E. Boven Schedule dependence of sensitivity to 2′, 2′-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours Biochem Pharmacol 48 1994 1327 1339
8. V. Heinemann, L. Schulz, R.D. Issels, and W. Plunkett Gemcitabine: A modulator of intracellular nucleotide and deoxynucleotide metabolism Semin Oncol 22 4 Suppl. 11 1995 11 18
9. V. Heinemann, Y.Z. Xu, and S. Chubb Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: A mechanism of self-potentiation Cancer Res 52 1992 533 539
10. C.H. Baker, J. Banzon, and J.M. Bollinger 2′-Deoxy-2′- methylenecytidine and 2′-deoxy-2′, 2′-difluorocytidine 5′-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase J Med Chem 34 1991 1879 1884
11. V.A. Zakian Telomeres: beginning to understand the end Science 270 1995 1601 1607 (Pubitemid 26002435)
12. E.H. Blackburn Structure and function of telomeres Nature 350 1991 569 573 (Pubitemid 21912269)
13. R.K. Moyzis, J.M. Buckingham, and L.S. Cram A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes Proc Natl Acad Sci U S A 85 1988 6622 6626
14. J. Meyne, R.L. Ratliff, and R.K. Moyzis Conservation of the human telomere sequence (TTAGGG)n among vertebrates Proc Natl Acad Sci U S A 86 1989 7049 7053 (Pubitemid 19240864)
15. V.A. Zakian Structure and function of telomeres Annu Rev Genet 23 1989 579 604 (Pubitemid 20033416)
16. T. de Lange, L. Shiue, and R.M. Myers Structure and variability of human chromosome ends Mol Cell Biol 10 1990 518 527
17. G.B. Morin The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats Cell 59 1989 521 529 (Pubitemid 19284465)
18. C.M. Counter, A.A. Avilion, and C.E. LeFeuvre Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity EMBO J 11 1992 1921 1929
19. N.W. Kim, M.A. Piatyszek, and K.R. Prowse Specific association of human telomerase activity with immortal cells and cancer Science 266 1994 2011 2015
20. E. Hiyama, K. Hiyama, and T. Yokoyama Correlating telomerase activity levels with human neuroblastoma outcomes Nat Med 1 1995 249 255
21. C.M. Counter, H.W. Hirte, S. Bacchetti, and C.B. Harley Telomerase activity in human ovarian carcinoma Proc Natl Acad Sci U S A 91 1994 2900 2904 (Pubitemid 24130141)
22. R. Tang, A.J. Cheng, J.Y. Wang, and T.C. Wang Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis Cancer Res 58 1998 4052 4054 (Pubitemid 28440553)
23. C. Colgin, and R. Reddel Telomere biology: A new player in the end zone Current Biology 14 2004 R901 R902
24. A. Smogorzewska, B. van Steensel, and A. Bianchi Control of human telomere length by TRF1 and TRF2 Mol Cell Biol 20 2000 1659 1668 (Pubitemid 30100185)
25. A. Smogorzewska, and T. de Lange Regulation of telomerase by telomeric proteins Annu Rev Biochem 73 2004 177 208 (Pubitemid 39050367)
26. J.T. Kadonaga, and R. Tjian Affinity purification of sequence-specific DNA binding proteins Proc Natl Acad Sci U S A 83 1986 5889 5893 (Pubitemid 16000619)
27. E. Sugiyama, N. Kaniwa, and S.R. Kim Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms J Clin Pharmacokinet 49 2010 549 558
28. P. Muñoz, R. Blanco, J.M. Flores, and M.A. Blasco XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer Nat Genet 37 2005 1063 1071 (Pubitemid 41486658)
29. L.D. McDaniel, R.A. Schultz, and E.C. Friedberg TERF2-XPF: caught in the middle; beginnings from the end DNA Repair (Amst) 5 2006 868 872 (Pubitemid 43928892)
30. R. Blanco, P. Muñoz, J.M. Flores, P. Klatt, and M.A. Blasco Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis Genes Dev 21 2007 206 220 (Pubitemid 46155814)
31. B. Laquente, C. Lacasa, and M.M. Ginestà Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model Mol Cancer Ther 7 2008 638 647 (Pubitemid 351482146)